Key result
Deprescribing antihypertensives in older adults remains poorly defined and requires individualized decision-making.
Why the study?
The effects of deprescribing antihypertensive medications in older adults remain uncertain, with limited and low-event-rate evidence on key cardiovascular outcomes.
Does deprescribing antihypertensive medications reduce all-cause mortality in adults aged 65 years and older?
Does deprescribing antihypertensive medications reduce all-cause mortality in adults aged 65 years and older?
Deprescribing antihypertensive medications in older adults has an uncertain effect on all-cause mortality but may increase the risk of heart failure, emphasizing the need for individualized decision-making.
The effects of deprescribing antihypertensive medications in older adults remain uncertain. The limited and low-event-rate evidence on key cardiovascular outcomes for older individuals highlights the need for individualized decision-making, especially in frail and multimorbid populations. This review provides a foundation for future research to address gaps and guide safer deprescribing practices in older adults in routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Floriani et al. (2026) studied this question. Deprescribing antihypertensive medications in older adults is poorly defined, requiring individualized decision-making due to low-event-rate evidence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: